LKT Labs

Biochemicals for Life Science Research

Homoharringtonine

Homoharringtonine

Product ID H5750
Cas No. 26833-87-4
Purity ≥97%
Product Unit SizeCostQuantityStock
1 mg $44.80 In stock
5 mg $126.80 In stock
10 mg $154.40 In stock
Bulk Quote

Quicklinks

Description

Homoharringtonine is an alkaloid found in Cephalotaxus that binds the A site of the 60 S ribosomal subunit, preventing aminoacyl-tRNA binding, inhibiting protein translation, and inducing cell death; it exhibits anticancer chemotherapeutic and immunosuppressive activities. Homoharringtonine is clinically used to treat chronic myelogenous leukemia (CML) and is currently in clinical trials as a potential treatment for acute myelogenous leukemia (AML) and myelodysplastic syndrome. In clinical subjects, homoharringtonine decreases the number of CD34+, CD117+ cells.

Product Info

Cas No.

26833-87-4
Purity

≥97%
Formula

C29H39NO9
Formula Wt.

545.62
Melting Point

143-145°C
Solubility

Soluble in DMSO (50 mg/mL), ethanol (25 mg/mL). Slightly soluble in chloroform, methanol.
Appearance

White Powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

H5750 MSDS PDF
Info Sheet

H5750 Info Sheet PDF
Brochures

Natural Products Booklet

References

Gandhi V, Plunkett W, Cortes JE. Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia. Clin Cancer Res. 2014 Apr 1;20(7):1735-40. PMID: 24501394.

Daver N, Vega-Ruiz A, Kantarjian HM, et al. A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome. Eur J Cancer Care (Engl). 2013 Sep;22(5):605-11. PMID: 23701251.

Li YF, Deng Z, Din BH, et al. Effect of homoharringtonine on bone marrow CD34 + CD117 + cells in patients with chronic myelogenous leukemia. Leuk Lymphoma. 2012 May;53(5):934-9. PMID: 22054289.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M1879

    Metoprolol Tartrate

    β1-adrenergic antagonist.
    ≥98%
  • A9435

    Axitinib

    VEGFR inhibitor.
    ≥98%
  • S7717

    Sterigmatocystin

    Mycotoxin produced by Aspergillus; carcinogen.
    ≥98%
  • C002041

    Cabazitaxel

    Taxoid that disrupts the microtubular network in c...
    ≥98%
  • H1894

    Hexestrol

    Synthetic catechol; ER agonist, microtubule polyme...
    ≥98%
  • A4930

    7-Aminoactinomycin D

    Actinomycin derivative used to study apoptosis and...
    ≥97%
  • J889280

    JWH 015

    Cannabinoid receptor 2 selective agonist.
    ≥98%
  • A0823

    N-Acetyl-S-(N′-methylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, antioxidant; aldehyde dehy...
    ≥98%
  • C0044

    CAL101

    p110δ PI3K inhibitor.
    ≥98%
  • G5320

    GNF-2

    Abl inhibitor.
    ≥98%
  • T0097

    10-Deacetyltaxol B

    Diterpene found in Taxus; potential microtubule de...
    ≥98%
  • P0005

    Pituitary Adenylate Cyclase-activating Polypeptide (1-27), human, sheep, rat

    Endogenous peptide, involved in paracrine and auto...
    ≥95%
  • P2833

    Peptide Histidine Isoleucine, rat

    Endogenous peptide hormone; VPAC2 activator.
    ≥95%
  • L9600

    LY-2090314

    GSK-3 inhibitor.
    ≥98%
  • M7531

    γ-1 Melanocyte Stimulating Hormone

    Endogenous peptide hormone derived from POMC, invo...
    ≥98%
  • Z0252

    Zanamivir

    Neuraminidase inhibitor.
    ≥98%
  • X0384

    XAV-939

    Tankyrase inhibitor.
    ≥95%
  • E6396

    EPZ005687

    EZH2 HMT inhibitor.
    ≥99%
  • C0275

    Castanospermine

    O-GlcNAcase inhibitor.
    ≥98%
  • R3374

    Risedronic Acid

    Bisphosphonate; inhibits transfer of farnesyl pyro...
    ≥97%